Monday, February 4, 2019

Breastfeeding Is Still Best

Breastfeeding Is Still Best: The benefits of breastfeeding are wide-ranging.

Vaping May Pose Big Risk for Smoking in Otherwise 'Low-Risk' Kids

Vaping May Pose Big Risk for Smoking in Otherwise 'Low-Risk' Kids: The kind of teenager least interested in smoking appears to be the type most likely to try a cigarette after they experiment with vaping, a new study indicates.

Transparent Hospital Pricing Exposes Wild Fluctuation, Even Within Miles | Kaiser Health News

Transparent Hospital Pricing Exposes Wild Fluctuation, Even Within Miles | Kaiser Health News: A new federal rule requires hospitals to post their prices online. These lists reveal the wildly different charges for basic procedures and services, but consumers will have a hard time putting this information to use.

Patients Suffer When Health Care Behemoths Quarrel Over Contracts | Kaiser Health News

Patients Suffer When Health Care Behemoths Quarrel Over Contracts | Kaiser Health News: The latest example is Sutter Health and Anthem Blue Cross, whose failure to seal a deal is causing Anthem members to worry they may not have access to one of the dominant hospital chains in Northern California. Across the U.S., the stakes in such contract fights have risen, as health systems and insurers battle to increase their market share.

Friday, February 1, 2019

As Millions of Teens Get Hooked on Vaping, What Works to Help Them Quit?

As Millions of Teens Get Hooked on Vaping, What Works to Help Them Quit?: E-cigarette use is surging among American teenagers, with millions of kids flirting with nicotine addiction by regularly vaping.

Trump administration to eliminate safe harbors for drug rebates to PBMs | FierceHealthcare

Trump administration to eliminate safe harbors for drug rebates to PBMs | FierceHealthcare

Senators threaten to force drug company CEOs to testify on prices | FierceHealthcare

Senators threaten to force drug company CEOs to testify on prices | FierceHealthcare: Republicans and Democrats found an issue they could agree on this week: They are particularly unhappy with drugmakers. At a Senate Finance Committee hearing on the problem of high prescription drug prices, leaders said the lack of pharmaceutical company leadership in the room wasn't for lack of invites.